Comparing Anti-VEGF Therapies: Real-World Insights on Efficacy, Safety, and Dosing
Charles Turck, PharmD, BCPS, BCCCP
Michael Javaheri, MD
Optimizing Anti-VEGF Sequencing: Strategies to Reduce Burden and Personalize Care
Brian P. McDonough, MD, FAAFP
Mitchell J. Goff
Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Joseph M. Coney, MD
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Marlene Mimi Maeusli, PhD.
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Ryan Quigley
Michael Twa , MD
David Berntsen, MD
Insights and Updates: New Data on Next-Generation Retinal Treatments
Durga Borkar, MD, MMCi
Veeral Sheth, MD, MBA, FASRS, FACS
Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
Christina Y. Weng, MD, MBA, FASRS
Mark T. Dunbar, OD, FAAO
David A. Eichenbaum, MD, FAAO
Jaclyn Garlich, OD, FAAO
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
High Myopia and Visual Disability: New Evidence from a Spanish Clinical Cohort
Providing a Lifetime of Eye Health Care
Jessica O. Yu, OD, FAAO, FSLS
Toric and Multifocal Lenses
Darryl Glover Jr., OD
Britt Gustafson, OD
Selina McGee, OD, FAAO
Contact Lenses Driving Business
Building Momentum in Your Contact Lens Business
Technology in the Contact Lens Space
Don't Miss the Opportunity in Your Chair
Shelby Brogdon, OD
Debunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
Jeffrey Walline, OD, PhD
Biomarkers and Second-Generation Treatments
John W. Kitchens, MD
Sara LeMay, OD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.